Fernando O Carreño (Fernando Carreño)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 14

Top Topics

Venous Thromboembolism

Top Venues

CPT: pharmacometrics & systems pharmacology

Clinical pharmacokinetics

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Fernando O Carreño, Jacqueline G Gerhart, Victória Etges Helfer, Jaydeep Sinha, Karan R Kumar, Carl M J Kirkpatrick, Christoph P Hornik, Daniel Gonzalez, null null
Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population. Clinical pharmacokinetics 63 (7) (2024)
Fernando O Carreño, Jacqueline G Gerhart, Victória Etges Helfer, Jaydeep Sinha, Karan R Kumar, Carl M J Kirkpatrick, Christoph P Hornik, Daniel Gonzalez, null null
Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population. Clinical pharmacokinetics 63 (7) (2024)
Fernando O Carreño, Jacqueline G Gerhart, Victória Etges Helfer, Jaydeep Sinha, Karan R Kumar, Carl M J Kirkpatrick, Christoph P Hornik, Daniel Gonzalez, null null
Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population. Clinical pharmacokinetics (2024)
Fernando O Carreño, Jacqueline G Gerhart, Victória Etges Helfer, Jaydeep Sinha, Karan R Kumar, Carl M J Kirkpatrick, Christoph P Hornik, Daniel Gonzalez, null null
Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population. Clinical pharmacokinetics (2024)
Bruna Bernar Dias, Fernando O Carreño, Victória Etges Helfer, Laura Ben Olivo, Keli Jaqueline Staudt, Karina Paese, Fabiano Barreto, Fabíola Schons Meyer, Ana Paula Herrmann, Sílvia Stanisçuaski Guterres, Stela Maris Kuze Rates, Bibiana Verlindo de Araujo, Iñaki F Trocóniz, Teresa Dalla Costa
Pharmacokinetic/pharmacodynamic modeling of cortical dopamine concentrations after quetiapine lipid core nanocapsules administration to schizophrenia phenotyped rats. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Bruna Bernar Dias, Fernando O Carreño, Victória Etges Helfer, Laura Ben Olivo, Keli Jaqueline Staudt, Karina Paese, Fabiano Barreto, Fabíola Schons Meyer, Ana Paula Herrmann, Sílvia Stanisçuaski Guterres, Stela Maris Kuze Rates, Bibiana Verlindo de Araujo, Iñaki F Trocóniz, Teresa Dalla Costa
Pharmacokinetic/pharmacodynamic modeling of cortical dopamine concentrations after quetiapine lipid core nanocapsules administration to schizophrenia phenotyped rats. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Bruna Bernar Dias, Fernando O Carreño, Victória Etges Helfer, Laura Ben Olivo, Keli Jaqueline Staudt, Karina Paese, Fabiano Barreto, Fabíola Schons Meyer, Ana Paula Herrmann, Sílvia Stanisçuaski Guterres, Stela Maris Kuze Rates, Bibiana Verlindo de Araujo, Iñaki F Trocóniz, Teresa Dalla Costa
Pharmacokinetic/pharmacodynamic modeling of cortical dopamine concentrations after quetiapine lipid core nanocapsules administration to schizophrenia phenotyped rats. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Bruna Bernar Dias, Fernando O Carreño, Victória Etges Helfer, Laura Ben Olivo, Keli Jaqueline Staudt, Karina Paese, Fabiano Barreto, Fabíola Schons Meyer, Ana Paula Herrmann, Sílvia Stanisçuaski Guterres, Stela Maris Kuze Rates, Bibiana Verlindo de Araujo, Iñaki F Trocóniz, Teresa Dalla Costa
Pharmacokinetic/pharmacodynamic modeling of cortical dopamine concentrations after quetiapine lipid core nanocapsules administration to schizophrenia phenotyped rats. CPT: pharmacometrics & systems pharmacology (2024)
Fernando O Carreño, Jacqueline G Gerhart, Victória Etges Helfer, Jaydeep Sinha, Karan R Kumar, Carl M J Kirkpatrick, Christoph P Hornik, Daniel Gonzalez, null null
Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population. Clinical pharmacokinetics 63 (7) (2024)
Fernando O Carreño, Jacqueline G Gerhart, Victória Etges Helfer, Jaydeep Sinha, Karan R Kumar, Carl M J Kirkpatrick, Christoph P Hornik, Daniel Gonzalez, null null
Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population. Clinical pharmacokinetics 63 (7) (2024)
Bruna Bernar Dias, Fernando O Carreño, Victória Etges Helfer, Laura Ben Olivo, Keli Jaqueline Staudt, Karina Paese, Fabiano Barreto, Fabíola Schons Meyer, Ana Paula Herrmann, Sílvia Stanisçuaski Guterres, Stela Maris Kuze Rates, Bibiana Verlindo de Araujo, Iñaki F Trocóniz, Teresa Dalla Costa
Pharmacokinetic/pharmacodynamic modeling of cortical dopamine concentrations after quetiapine lipid core nanocapsules administration to schizophrenia phenotyped rats. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Bruna Bernar Dias, Fernando O Carreño, Victória Etges Helfer, Laura Ben Olivo, Keli Jaqueline Staudt, Karina Paese, Fabiano Barreto, Fabíola Schons Meyer, Ana Paula Herrmann, Sílvia Stanisçuaski Guterres, Stela Maris Kuze Rates, Bibiana Verlindo de Araujo, Iñaki F Trocóniz, Teresa Dalla Costa
Pharmacokinetic/pharmacodynamic modeling of cortical dopamine concentrations after quetiapine lipid core nanocapsules administration to schizophrenia phenotyped rats. CPT: pharmacometrics & systems pharmacology 13 (4) (2024)
Jacqueline G Gerhart, Fernando O Carreño, Jennifer Lynn Ford, Andrea N Edginton, Eliana M Perrin, Kevin M Watt, William J Muller, Andrew M Atz, Amira Al-Uzri, Paula Delmore, Daniel Gonzalez, null null
Use of physiologically-based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity. CPT: pharmacometrics & systems pharmacology 11 (6) (2022)
Jacqueline G Gerhart, Fernando O Carreño, Matthew Shane Loop, And Craig R Lee, Andrea N Edginton, Jaydeep Sinha, Karan R Kumar, Carl M J Kirkpatrick, Christoph P Hornik, Daniel Gonzalez, null null
Use of Real-World Data and Physiologically-Based Pharmacokinetic Modeling to Characterize Enoxaparin Disposition in Children With Obesity. Clinical pharmacology and therapeutics 112 (2) (2022)